← Back to Search

Behavioral Intervention

Sleep and Circadian Rhythm + Memory Support for Sleep Disorders

N/A

Recruiting

Led By Allison Harvey, PhD

Research Sponsored by University of California, Berkeley

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up]

Awards & highlights

Study Summary

This trial tests if a new intervention can help improve sleep, reduce disability, and improve memory in people 50+ with mental illness.

Who is the study for?

This trial is for individuals aged 50 and older who speak English, have mobility issues, low income, and show no signs of cognitive impairment. They must be experiencing sleep or circadian disturbances but not severe untreated sleep apnea or other conditions that severely affect sleep. Participants need to consent to communication between researchers and their medical providers.Check my eligibility

What is being tested?

The study tests a new Memory Support Intervention (MSI) designed to improve treatment outcomes by enhancing patient memory. It focuses on people with mental illness suffering from sleep disorders and aims to see if MSI can better their sleep patterns, daily functioning, and memory retention.See study design

What are the potential side effects?

Since this is a psychological intervention focusing on improving memory support through behavioral techniques rather than medication, specific side effects are not listed like those for drug trials. However, participants may experience changes in mood or stress levels due to the nature of the therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up]

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 4 of treatment as well as post treatment, defined as two weeks after the final therapy session (i.e. 8-10 weeks after the initial intake interview) to 6-month follow-up to 12-month follow-up] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient-Reported Outcomes Measurement Information System - Sleep Disturbance

Satisfaction with Life Scale

Sheehan Disability Scale

Secondary outcome measures

Adapted Brief Disability Scale

Cognitive Failures Questionnaire

Composite Sleep Health Score

+21 more

Other outcome measures

Adverse events checklist

Credibility Expectancy Questionnaire

Montreal Cognitive Assessment (MoCA)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TranS-C+MSIExperimental Treatment2 Interventions

Transdiagnostic Intervention for Sleep and Circadian Dysfunction will be combined with the Memory Support Intervention

Group II: TranS-C aloneActive Control1 Intervention

The Transdiagnostic Sleep and Circadian Intervention will be delivered alone

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Transdiagnostic Intervention for Sleep and Circadian Dysfunction

2015

N/A

~130

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, BerkeleyLead Sponsor

181 Previous Clinical Trials

720,978 Total Patients Enrolled

Allison Harvey, PhDPrincipal InvestigatorUniversity of California, Berkeley

9 Previous Clinical Trials

1,941 Total Patients Enrolled

Media Library

Memory Support Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05986604 — N/A

Sleep Disorders Research Study Groups: TranS-C+MSI, TranS-C alone

Sleep Disorders Clinical Trial 2023: Memory Support Intervention Highlights & Side Effects. Trial Name: NCT05986604 — N/A

Memory Support Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05986604 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any participants still able to join this trial?

"According to its listing on clinicaltrials.gov, this medical trial is not currently accepting new enrollments - the original posting was made November 1st 2023 and last updated August 2nd 2023. Despite that, 131 other studies are still actively recruiting candidates."

Answered by AI

What goals are being sought after with this clinical experiment?

"This trial will be evaluated across a 8-10 week baseline to 6 and 12 month follow-up, with the primary outcome measure being Sheehan Disability Scale. Secondary outcomes include Positive and Negative Affect Scale (positive scores ranging from 10-15, negative from 10-50), World Health Organization's Disability Assessment Schedule 2.0 (WHODAS 2.0) which measures functional impairment, as well as Cognitive Failures Questionnaire (scores range 0-100)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment

Allison Harvey 2024. "NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05986604.